DaVita Q1 FY26: where the revenue came from and where it went
The whole income statement of DaVita for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jan 1 – Mar 31, 2026
- Reported
- May 5, 2026
Revenue$3.42B
+6% year over year
Gross profit$1.08B
32% margin
Operating profit$0.48B
14% margin
Net profit$0.20B
6% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 3.42 | 100% | +6% |
| U.S.Dialysis & related lab | 2.92 | 86% | +4% |
| All other | 0.49 | 14% | +20% |
| Cost of revenue | −2.33 | 68% | |
| Gross profit | 1.08 | 32% margin | +1pp |
| G&A | −0.42 | 13% | +1pp |
| Other | −0.18 | 5% | +0pp |
| Operating profit | 0.48 | 14% margin | +0pp |
| Interest & other costs | −0.22 | ||
| Tax | −0.07 | ||
| Net profit | 0.20 | 6% margin | +1pp |
151 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest